BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1218388)

  • 21. Second trimester termination by intra-uterine prostaglandin F 2 . Clinical and hormonal results with observations on induced lactation and chronoperiodicity.
    Shearman R; Smith I; Korda A
    J Reprod Med; 1972 Dec; 9(6):448-52. PubMed ID: 4648927
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
    Miyamoto T
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):203-20. PubMed ID: 199477
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach.
    Gerhard I; Runnebaum B
    Biol Res Pregnancy Perinatol; 1984; 5(4):157-73. PubMed ID: 6084523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies of the human chorionic gonadotropin levels in threatened abortion by the passive hemagglutination inhibition and Gravindex tests in the 1st and 2d trimesters of pregnancy].
    Berliński B; Wesołowski E; Berliński T
    Wiad Lek; 1980 Dec; 33(23):1887-9. PubMed ID: 7245748
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognosis and treatment of threatened abortion. A. Prognostic value of maternal serum determination of choriogonadotropin and its free alpha and beta subunits in threatened abortion of the first trimester: correlation with ultrasonographic examination].
    Gaspard U; Schaaps JP; Piront F; Deville JL; Reuter AM; Vrindts-Gevaert Y; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):62-6. PubMed ID: 7451883
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion.
    Camejo MI; Proverbio F; Febres F; Casart YC
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):181-4. PubMed ID: 12860338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the diagnosis of first-trimester pregnancy problems.
    Deutchman M
    Am Fam Physician; 1991 Nov; 44(5 Suppl):15S-30S. PubMed ID: 1950980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The prognostic significance of various hormonal parameters in pregnancies complicated by threatened abortion].
    Marsico S; Mancuso A; Oliva A; Pizzo A
    Minerva Ginecol; 1984; 36(7-8):381-9. PubMed ID: 6208512
    [No Abstract]   [Full Text] [Related]  

  • 29. [The clinical management for abortion in early gestational weeks].
    Sagara Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):267-72. PubMed ID: 3958523
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative characteristics of echography and human chorionic gonadotropin values in the detection of pathology in the 1st trimester of pregnancy].
    Ilieva K; Penev I; Pavlova F
    Akush Ginekol (Sofiia); 1981; 20(5):365-8. PubMed ID: 7325325
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic procedures in threatened abortion.
    Hertz JB
    Obstet Gynecol; 1984 Aug; 64(2):223-9. PubMed ID: 6738955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corpus luteum function in early pregnancy.
    Yoshimi T; Strott CA; Marshall JR; Lipsett MB
    J Clin Endocrinol Metab; 1969 Feb; 29(2):225-30. PubMed ID: 5764544
    [No Abstract]   [Full Text] [Related]  

  • 33. [SP1-glycoprotein and beta-HCG during the first trimester in physiological, ectopic and abortive pregnancies].
    Fanizza G; Pizza M; Ranieri DM
    Ann Ostet Ginecol Med Perinat; 1987; 108(2):77-82. PubMed ID: 3498424
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnostic value of plasma progesterone in nonendocrine incipient abortions in the 1st trimester].
    Rachev E
    Akush Ginekol (Sofiia); 1983; 22(4):270-3. PubMed ID: 6670697
    [No Abstract]   [Full Text] [Related]  

  • 35. Episodic secretion of human chorionic gonadotropin.
    Ayala AR; Bustos H; Antúnez O; González E
    Arch Invest Med (Mex); 1984; 15(2):147-53. PubMed ID: 6487004
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of failed first trimester pregnancy.
    Daly S; Prendiville W
    Ir Med J; 1997 Mar; 90(2):52. PubMed ID: 9105123
    [No Abstract]   [Full Text] [Related]  

  • 37. Corpus luteum activity in tubal pregnancy.
    Sauer MV; Gorrill MJ; Rodi IA; Yeko TR; Buster JE
    Obstet Gynecol; 1988 May; 71(5):667-70. PubMed ID: 3357652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New thoughts in exploring the pathogenesis, diagnosis, and treatment of threatened abortion.
    Zhou J; Huang Z; Pan X; Leung WT; Li C; Chen L; Zhang Y; Wang L; Sima Y; Zhang N; Qiu X; Li L; Wang L
    Biosci Trends; 2019; 13(3):284-285. PubMed ID: 31327799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma hormone changes during infusions of prostaglandins F2alpha and E2 for therapeutic abortion.
    Newton J; Collins W
    Adv Biosci; 1973; 9():689-99. PubMed ID: 4805881
    [No Abstract]   [Full Text] [Related]  

  • 40. 17-Hydroxyprogesterone level as a marker for corpus luteum function in aborters versus nonaborters.
    Check JH; Vaze MM; Epstein R; Wu CH; Quattrocchi J; Vetter B
    Int J Fertil; 1990; 35(2):112-5. PubMed ID: 1970979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.